Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
38.85
+0.76 (2.00%)
At close: Nov 20, 2024, 4:00 PM
39.45
+0.60 (1.54%)
Pre-market: Nov 21, 2024, 7:23 AM EST
Verona Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 5.62 | - | 0.46 | 40 | - | - | Upgrade
|
| Revenue Growth (YoY) | 1127.95% | - | -98.86% | - | - | - | Upgrade
|
| Cost of Revenue | 0.54 | - | 0.35 | - | - | - | Upgrade
|
| Gross Profit | 5.08 | - | 0.11 | 40 | - | - | Upgrade
|
| Selling, General & Admin | 119.64 | 50.35 | 24.58 | 33.91 | 29.77 | 9.99 | Upgrade
|
| Research & Development | 36.75 | 16.11 | 39.65 | 63.78 | 36.24 | 33.13 | Upgrade
|
| Operating Expenses | 156.39 | 66.47 | 64.23 | 97.68 | 66.01 | 43.12 | Upgrade
|
| Operating Income | -151.3 | -66.47 | -64.12 | -57.68 | -66.01 | -43.12 | Upgrade
|
| Interest Expense | -13.85 | -2.06 | -0.52 | -0.34 | -0.04 | - | Upgrade
|
| Interest & Investment Income | 14.56 | 12.76 | 2.82 | 0.01 | 0.12 | 0.96 | Upgrade
|
| Currency Exchange Gain (Loss) | 2.49 | 1.87 | -3.82 | 0.18 | 2.06 | -0.4 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | 2.25 | -1.14 | 2.07 | Upgrade
|
| EBT Excluding Unusual Items | -148.11 | -53.9 | -65.63 | -55.59 | -65 | -40.49 | Upgrade
|
| Other Unusual Items | -3.65 | - | -2.82 | - | - | - | Upgrade
|
| Pretax Income | -151.76 | -53.9 | -68.45 | -55.59 | -65 | -40.49 | Upgrade
|
| Income Tax Expense | 1.97 | 0.47 | 0.25 | -0.02 | 0.15 | 0.07 | Upgrade
|
| Net Income | -153.72 | -54.37 | -68.7 | -55.57 | -65.15 | -40.56 | Upgrade
|
| Net Income to Common | -153.72 | -54.37 | -68.7 | -55.57 | -65.15 | -40.56 | Upgrade
|
| Shares Outstanding (Basic) | 81 | 79 | 66 | 59 | 33 | 13 | Upgrade
|
| Shares Outstanding (Diluted) | 81 | 79 | 66 | 59 | 33 | 13 | Upgrade
|
| Shares Change (YoY) | 3.55% | 19.86% | 11.81% | 79.97% | 149.64% | 0.21% | Upgrade
|
| EPS (Basic) | -1.90 | -0.69 | -1.04 | -0.94 | -1.98 | -3.08 | Upgrade
|
| EPS (Diluted) | -1.93 | -0.72 | -1.04 | -0.94 | -1.98 | -3.08 | Upgrade
|
| Free Cash Flow | -103.81 | -50.22 | -59.89 | -33.27 | -45.16 | -42.92 | Upgrade
|
| Free Cash Flow Per Share | -1.28 | -0.63 | -0.91 | -0.56 | -1.37 | -3.26 | Upgrade
|
| Gross Margin | 90.34% | - | 24.45% | 100.00% | - | - | Upgrade
|
| Operating Margin | -2690.33% | - | -13999.13% | -144.21% | - | - | Upgrade
|
| Profit Margin | -2733.34% | - | -15000.22% | -138.92% | - | - | Upgrade
|
| Free Cash Flow Margin | -1845.91% | - | -13076.64% | -83.16% | - | - | Upgrade
|
| EBITDA | -150.3 | -65.79 | -63.48 | -57.05 | -65.39 | -42.61 | Upgrade
|
| EBITDA Margin | - | - | - | -142.63% | - | - | Upgrade
|
| D&A For EBITDA | 1.01 | 0.68 | 0.64 | 0.63 | 0.62 | 0.51 | Upgrade
|
| EBIT | -151.3 | -66.47 | -64.12 | -57.68 | -66.01 | -43.12 | Upgrade
|
| EBIT Margin | - | - | - | -144.21% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.